Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
104.00    0.80 (0.78%)
Bid:
104.00
Ask:
105.20
Spread: 1.20 (1.154%)
Market Cap: £170.50m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Interim Management Statement

7 Nov 2013 07:00

RNS Number : 3806S
Synthomer PLC
07 November 2013
 



7th November 2013

 

SYNTHOMER PLC

 

INTERIM MANAGEMENT STATEMENT

 

Synthomer plc ("Synthomer" or "the Group") today issues its interim management statement for the period 1 July to 6 November 2013.

 

Trading

 

The Group has performed broadly in line with the Board's expectations since the last update provided at the interim results in August.

 

Trading conditions in Europe have remained challenging, particularly in construction related areas, resulting in Europe and North America (ENA) operating profit being slightly below the same period last year. Whilst volumes showed some improvement over the prior year, the softer margins we saw in the first half persisted. In a difficult demand environment, a number of pricing actions have been taken.

 

In Asia and ROW, trading has remained strong. The solid demand for nitrile products seen during the first half of the year continued throughout the period reflecting the ongoing benefits of new product launches at the beginning of the year.

 

The Group's financial position remains robust with net debt at the period end slightly lower than the level reported at the interim results. As we approach the end of the year, we expect the seasonal working capital profile of the business to ease, further improving our net debt position.

 

Outlook

 

In Europe, where we have seen no material improvement in market conditions to date, we continue to expect second half operating profit to be lower than the first half of the year. This will reflect the impact of normal seasonal factors and is expected to deliver ENA profitability slightly below that achieved in the second half of the prior year. The Board continues to expect Asia and ROW operating profit in the second half to be in line with the first half, substantially ahead of the prior year.

 

Commenting Adrian Whitfield, Chief Executive Officer, said:

 

"Whilst challenging market conditions in Europe have persisted, our business has held up well and strong cash generation is enabling us to maintain investment in emerging market growth. The nitrile business in Asia has continued its solid performance and we are encouraged by the demand growth in the region."

 

Enquiries:

 

Adrian Whitfield, Chief Executive Officer

Charles Armitstead / Rosie Oddy

David Blackwood, Chief Financial Officer

Pendomer Communications

Tel: 01279 442791

Tel: 020 3603 5220

 

The company will host a conference call for analysts at 8.30am today. Please contact Pendomer Communications on 020 3603 5220 for dial in details.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUNSSROAAARAA
Date   Source Headline
2nd Jan 20259:00 amRNSDirectorate Change
31st Oct 20247:00 amRNSTrading statement - Autumn 2024
17th Oct 20244:01 pmRNSHolding(s) in Company
14th Oct 20241:51 pmRNSHolding(s) in Company
27th Sep 202412:46 pmRNSHolding(s) in Company
19th Sep 20241:01 pmRNSHolding(s) in Company
13th Aug 20247:00 amRNSInterim results
18th Jul 202412:53 pmRNSChair succession and other board changes
17th May 20248:20 amRNSPost Stabilisation Notice
9th May 20242:29 pmRNSResults of AGM
9th May 20247:00 amRNSTrading Statement - Spring 2024
1st May 20247:00 amRNSDivestment of Compounds completed
25th Apr 20244:30 pmRNSDirector/PDMR Shareholding
25th Apr 20244:20 pmRNSDirector/PDMR Shareholding
17th Apr 202410:43 amRNSTender offer results
15th Apr 20247:00 amRNSDivestment of Compounds
12th Apr 20247:00 amRNSPricing of senior notes
9th Apr 20243:47 pmRNSPre Stabilisation Notice
9th Apr 20248:09 amRNSNotice of tender offer
9th Apr 20248:09 amRNSProposed offering of senior notes
28th Mar 20242:38 pmRNSDirector/PDMR Shareholding
28th Mar 20242:38 pmRNSDirector/PDMR Shareholding
28th Mar 20242:10 pmRNSAnnual Financial Report and Notice of AGM
12th Mar 20247:00 amRNSFinal Results
30th Jan 20247:00 amRNSTrading Statement
17th Jan 20242:58 pmRNSExternal Appointment
15th Nov 20237:00 amRNSTrading statement - Autumn 2023
3rd Nov 20232:54 pmRNSDirector/PDMR Shareholding
23rd Oct 20231:58 pmRNSDirector/PDMR Shareholding
18th Oct 20237:00 amRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSDirector/PDMR Shareholding
16th Oct 20233:13 pmRNSHolding(s) in Company - CORRECTION
16th Oct 202312:06 pmRNSHolding(s) in Company
16th Oct 202312:03 pmRNSHolding(s) in Company
16th Oct 202311:57 amRNSHolding(s) in Company
16th Oct 20237:00 amRNSTotal Voting Rights
16th Oct 20237:00 amRNSPDMR and PCA Notification
13th Oct 20234:18 pmRNSHolding(s) in Company
13th Oct 202310:48 amRNSHolding(s) in Company
13th Oct 20237:00 amRNSResult of rump placing
12th Oct 20234:36 pmRNSResult of Equity Issue
12th Oct 202310:09 amRNSHolding(s) in Company
11th Oct 20239:39 amRNSHolding(s) in Company
11th Oct 20237:00 amRNSPDMR PCA Notification
10th Oct 20233:04 pmRNSHolding(s) in Company
10th Oct 202310:26 amRNSHolding(s) in Company
10th Oct 202310:26 amRNSHolding(s) in Company
9th Oct 20233:08 pmRNSHolding(s) in Company
9th Oct 20239:44 amRNSHolding(s) in Company
6th Oct 20231:56 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.